Microglia monitor and protect neuronal function through specialized somatic purinergic junctions.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
31 01 2020
Historique:
received: 12 04 2019
revised: 14 10 2019
accepted: 03 12 2019
pubmed: 14 12 2019
medline: 16 4 2020
entrez: 14 12 2019
Statut: ppublish

Résumé

Microglia are the main immune cells in the brain and have roles in brain homeostasis and neurological diseases. Mechanisms underlying microglia-neuron communication remain elusive. Here, we identified an interaction site between neuronal cell bodies and microglial processes in mouse and human brain. Somatic microglia-neuron junctions have a specialized nanoarchitecture optimized for purinergic signaling. Activity of neuronal mitochondria was linked with microglial junction formation, which was induced rapidly in response to neuronal activation and blocked by inhibition of P2Y12 receptors. Brain injury-induced changes at somatic junctions triggered P2Y12 receptor-dependent microglial neuroprotection, regulating neuronal calcium load and functional connectivity. Thus, microglial processes at these junctions could potentially monitor and protect neuronal functions.

Identifiants

pubmed: 31831638
pii: science.aax6752
doi: 10.1126/science.aax6752
doi:

Substances chimiques

Receptors, Purinergic P2Y12 0
Shab Potassium Channels 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

528-537

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM084136
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM109888
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Csaba Cserép (C)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Balázs Pósfai (B)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
Szentágothai János Doctoral School of Neuroscience, Semmelweis University, Budapest, Hungary.

Nikolett Lénárt (N)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Rebeka Fekete (R)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
Szentágothai János Doctoral School of Neuroscience, Semmelweis University, Budapest, Hungary.

Zsófia I László (ZI)

Szentágothai János Doctoral School of Neuroscience, Semmelweis University, Budapest, Hungary.
Momentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest, Hungary.

Zsolt Lele (Z)

Momentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest, Hungary.

Barbara Orsolits (B)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Gábor Molnár (G)

MTA-SZTE Research Group for Cortical Microcircuits of the Hungarian Academy of Sciences, Department of Physiology, Anatomy and Neuroscience, University of Szeged, Szeged, Hungary.

Steffanie Heindl (S)

Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.

Anett D Schwarcz (AD)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Katinka Ujvári (K)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Zsuzsanna Környei (Z)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Krisztina Tóth (K)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
Szentágothai János Doctoral School of Neuroscience, Semmelweis University, Budapest, Hungary.

Eszter Szabadits (E)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Beáta Sperlágh (B)

Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, Hungary.

Mária Baranyi (M)

Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, Hungary.

László Csiba (L)

MTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, Debrecen, Hungary.

Tibor Hortobágyi (T)

Institute of Pathology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Centre for Age-Related Medicine, SESAM, Stavanger University Hospital, Stavanger, Norway.

Zsófia Maglóczky (Z)

Human Brain Research Laboratory, Institute of Experimental Medicine, Budapest, Hungary.

Bernadett Martinecz (B)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

Gábor Szabó (G)

Medical Gene Technology Unit, Institute of Experimental Medicine, Budapest, Hungary.

Ferenc Erdélyi (F)

Medical Gene Technology Unit, Institute of Experimental Medicine, Budapest, Hungary.

Róbert Szipőcs (R)

Institute for Solid State Physics and Optics of Wigner RCP, Budapest, Hungary.

Michael M Tamkun (MM)

Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.

Benno Gesierich (B)

Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.

Marco Duering (M)

Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

István Katona (I)

Momentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest, Hungary.

Arthur Liesz (A)

Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Gábor Tamás (G)

MTA-SZTE Research Group for Cortical Microcircuits of the Hungarian Academy of Sciences, Department of Physiology, Anatomy and Neuroscience, University of Szeged, Szeged, Hungary.

Ádám Dénes (Á)

Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary. denes.adam@koki.mta.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH